Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Ann Hematol. 2024 Apr;103(4):1403-1407. doi: 10.1007/s00277-024-05643-w. Epub 2024 Jan 29.
Isolated pleural effusion is a rare manifestation of chronic graft versus host disease (cGVHD) after hematopoietic stem cell transplantation (HSCT). We herein report a 58-year-old woman presenting with massive pleural effusion approximately 1 year after allogeneic HSCT, who was successfully treated with corticosteroid. She had discontinued tacrolimus approximately 1 month before she presented with pleural effusion, which was attributed to cGVHD after a thorough exclusion process. This case illustrates a unique manifestation of atypical cGVHD and highlights the need for prompt therapy initiation.
孤立性胸腔积液是造血干细胞移植(HSCT)后慢性移植物抗宿主病(cGVHD)的罕见表现。本研究报告了一例 58 岁女性,在异基因 HSCT 后约 1 年出现大量胸腔积液,经皮质类固醇治疗后成功治愈。她在出现胸腔积液前约 1 个月停用了他克莫司,经彻底排除过程后归因于 cGVHD。该病例说明了非典型 cGVHD 的一种独特表现,并强调了及时开始治疗的必要性。